KENNEDY KOLLEEN T 4

What Happened

• Kolleen T. Kennedy, a director of ICU Medical, had two related transactions on May 13, 2026. She converted/exercised 1,254 derivative units (code M) at $0.00 and those 1,254 derivative shares were also recorded as disposed (code M) at $0.00. On the same date she was granted/awarded 1,475 shares (code A) at $0.00. All reported prices and values are $0.00 because these securities are restricted stock units (RSUs) rather than purchases for cash.

Key Details

• Transaction date: 2026-05-13. Prices reported: $0.00 for all items (RSUs have no exercise/purchase price).
• Transactions reported: conversion/exercise of 1,254 derivative units (M: acquired and immediately disposed) and grant/award of 1,475 RSUs (A: acquired).
• Shares owned after transaction: not specified in the provided Form 4 summary.
• Footnotes: F1 = these are Restricted Stock Units; F2 = RSUs have no purchase/exercise price; F3 = awards vest on the anniversary of grant or the next annual stockholder meeting, whichever is earlier.
• Filing timeliness: Reported and filed on 2026-05-13 (same-day reporting).

Context

• For retail investors: this was not an open-market buy or sell. The activity reflects RSU awards/vesting and a conversion event, not a cash purchase or a market sale. The same-day conversion and disposal of 1,254 units often indicates shares were surrendered/withheld (commonly for tax withholding), but the filing only shows the conversion/disposition — it does not state the reason.
• RSU grants and vesting are routine forms of director compensation and do not by themselves indicate a change in insider sentiment about the stock.